+44 (0) 1865 606333 enquiries@visibleanalytics.co.uk

New RWE frameworks, new analytical methods
but not yet much HTA acceptance; what is next?

Expert Workshop
July 27th, 2021 – 15:00-16:30 BST
moderated by Prof. Keith Abrams

Thank you to all the attendees, please find the recording of the complete webinar online here.

If you have any questions for our panellists or feedback for our organisers, please email us at enquiries@visibleanalytics.co.uk.

Recent advances in analytical methods for combining evidence from RCTs and non-RCTs, and the development of new frameworks for the inclusion of RWE in HTA have provided a greater insight on how issues around RWE uncertainty can be dealt with when estimating treatment effects for new technologies.

Join our panellists for a lively discussion as they debate using these novel analytical methods in HTA, and propose a newly developed framework for integrating non-RCTs in decision-making and explore acceptance of its use.

Dalia Dawoud, MSc, PhD

Dalia Dawoud, MSc, PhD

Senior Scientific Adviser, NICE

Sofia Dias, PhD

Sofia Dias, PhD

Professor, University of York

Thomas Debray, MSc, PhD

Thomas Debray, MSc, PhD

Associate Professor, UMC Utrecht

Grammati Sarri, MSc, PhD

Grammati Sarri, MSc, PhD

RWE Strategy Lead, Visible Analytics